inbiome’s Post

Entering the next phase of our global journey 🚀

A little later in the week than usual, but delivering your Industry Insight's! This week includes a bounce back for a diagnostics company pivoting post COVID; a Dutch MedTech implantable firm securing funding; Positive signs in the Orthopaedic sector; a novel wearable that might help detect breast cancer at home; UK investment into AI in health; a new $1bn Life Science Hub and a global news outlet highlighting the critical part HealthTech has to play in our future. Featuring: Cue Health / Biomedical Advanced Research and Development Authority (BARDA) / Ayub Khattak Xeltis / European Innovation Council and SMEs Executive Agency (EISMEA) / DaVita Venture Group / EQT Group / Kurma Partners / Vi Partners / Ysios Capital / Svetoslava Georgieva / Eliane Schutte Stryker / Zimmer Biomet / Bryan Hanson / Robert Cohen Jennifer Tseng Michelle Donelan MP / Matt Clifford / Jonathan Black Tony Wood CNN / Med-Tech Innovation / MedTech Dive / Tech.eu / MassDevice / Medical News Today / Endpoints News Links to all of the articles in the comments. #medtech #medicaltechnology #medicaldevices #lifesciences #industryinsights

FeelTect an Enterprise Ireland backed company emerged from BioInnovate Ireland, a renowned, clinical needs-led innovation programme, which I cannot mention often enough, successfully completed a €1.5 million investment from strategic Irish and international investors. During clinical immersion in Irish and US hospital systems, Founder and CEO, Dr Andrew Cameron, identified an unmet clinical need for the safe, effective, and consistent application of compression therapy, which is the primary treatment for millions of people worldwide with venous leg ulcers (#VLUs). FeelTect's flagship product, Tight Alright™, is the world's first #connectedhealth technology for measuring and remotely monitoring sub-bandage pressure during compression therapy. The Tight Alright technology is comprised of an advanced #wearable device, with multiple pressure sensors, that wirelessly connects with a digital platform. The technology 💡 unburdens care providers by enabling significant advancements in treatment application, patient self-management, and remote monitoring of compression therapy effectiveness.  📈 Studies show that 30% of VLUs are not healed within a year, causing significant impacts to patients' quality of life, while the amount of money spent on treating VLU patients in the UK alone equates to 40% of all cancer costs combined.  I would like to wish Andrew Cameron and his team much success for 2024. #woundcare #legulcer #sensortechnology #compressiontherapy #careproviders #digitalplatform https://lnkd.in/eutSchcv

When you're bringing cool lifechanging technology to the market, cool podcasters, reporters, and media outlets want to share your story. Check out VenoStent, Inc. CEO Timothy Boire's interview on Natalie Harms #HoustonInnovatorsPodcast to learn more about a cool MedTech innovation that's about to change life trajectory for #vascularsurgery patients. #savinglives #pragency #healthcareinnovation #getinthemedia

In the cutting-edge realm of biotech, have you ever thought about the potential of Digital Twin Technology? In our latest piece, we venture into this fascinating territory. You’d be amazed at how this innovative technology could revolutionize how cardiac diseases are detected. We're featuring ECG-Excellence, a trailblazing startup based in Nieuwerbrug, Zuid-Holland, The Netherlands. They are developing and marketing novel technology in ECG waveform diagnostics with a game-changing concept based on digital twin reconstructions. Under the helms of dynamic founder Hans Slijp, ECG-Excellence is marking its next-level credibility in early detection of cardiac diseases, outperforming current technologies, and promising significant cost reductions in clinical trials. Dive deep into our article to understand the complete landscape of this compelling development. Certainly, it has the potential to redefine the future of healthcare and technology. https://lnkd.in/esppRZka Join us in supporting and celebrating these incredible disruptions in biotech, health care, IT, medical and software spheres. #Biotechnology #DigitalTwinTechnology #CardiacDiseaseDetection #Startups #Innovation #ECGExcellence #HealthcareTech

Introducing the Second Runners-Up of CIMA Launch Pad 2023 - Team Disruptors! 🚀👏 Representing Ophtha Innovations, Team Disruptors has left us in awe with their groundbreaking innovation. Their product delves into the world of Image Processing and AI, unveiling an automatic Diabetic Retinopathy (DR) screening system that's a game-changer. 👁️🗨️ Ophtha's remarkable system not only provides DR severity classification of fundus images but also goes beyond, offering segmentation of pathological conditions. This cutting-edge approach makes it the most convenient and informative DR screening system available today. What's truly remarkable is that Ophtha's advanced technology can identify the earliest onset sign of DR – micro-aneurysms. This innovation is not only groundbreaking but also a beacon of hope for early diagnosis and intervention. Congratulations, Team Disruptors, for your incredible achievement! 🏆 We can't wait to see how this innovation transforms the medical field. Keep disrupting the status quo! 🚀 #LaunchPad2023 #Innovation #HealthTech

Is labs-on-chip technology the prodigy of protein-based medical diagnostics? We may have just unearthed a game-changer in the realm of healthcare - a revolution in progress. Today, we're shining the spotlight on Milan-based startup DIANAX S.r.l. and its founders Eugenio Iannone, Maurizio Moroni and orchestrated by Gabriele Bavagnoli who are leading the way in advancing protein-based diagnostics. Dianax is shifting paradigms by developing and manufacturing labs-on-chip - a technology that promises faster, more accessible, and affordable diagnostics. Yet, it is their remarkable blend of microfluidic innovations and electrochemistry detection systems, a first in diagnostics, which sets them apart in this endeavour. If you're engrossed by the prospects of this remarkable technology and the strides Dianax is making, delve into our fresh-off-the-press article for a deeper understanding of their mission, technology and why they might just be the herald of a new era in medical diagnostics. 🔗 https://lnkd.in/eWedrZ64 Let's celebrate technology that transforms lives. Let's hail disruptive inventions that dare to challenge the status-quo. #HealthCareInnovation #MedTech #StartUpFeatures #ProteinBasedDiagnostics #LabsOnChip